Jianying Wang

Title: Innovations and Contributions of Inventor Jianying Wang

Introduction

Jianying Wang is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of five patents to his name, Wang's work has the potential to impact various medical applications.

Latest Patents

Wang's latest patents include "Human monoclonal antibodies to activin receptor-like kinase-1." This invention relates to antibodies that bind to the extracellular domain of activin receptor-like kinase-1 (ALK-1) and function to abrogate the ALK-1/TGF-beta-1/Smad1 signaling pathway. The patent also covers methods for making these antibodies and their applications in therapeutic compositions. Another notable patent is for "Alpha5-beta1 antibodies and their uses," which provides isolated monoclonal antibodies that specifically bind to integrin α5β1 with high affinity. This patent includes methods for treating various cancers using these antibodies.

Career Highlights

Throughout his career, Jianying Wang has worked with leading companies in the biotechnology sector, including Pfizer Corporation and Amgen. His experience in these organizations has allowed him to develop innovative solutions and contribute to advancements in medical science.

Collaborations

Wang has collaborated with notable professionals in his field, including Michael Aidan North and Dana Dan Hu-Lowe. These collaborations have further enriched his research and development efforts.

Conclusion

Jianying Wang's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.